Schwartz Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Schwartz Investment Counsel's AMGN Position: Q2 2018 in Review
Schwartz Investment Counsel sold out of Amgen (AMGN) in Q2 2018, closing a stake of 143,149 shares — an estimated $24.4M sold.
Schwartz Investment Counsel first reported a position in AMGN in Q2 2013 and held it in 20 quarters. The position peaked at $49.3M in Q3 2017. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.
- Schwartz Investment Counsel reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
- Schwartz Investment Counsel sold 143,149 Amgen shares in Q2 2018, an estimated $24.4M.
- Schwartz Investment Counsel first reported a position in Amgen in Q2 2013 and held it in 20 quarters.
- Schwartz Investment Counsel's Amgen position peaked at $49.3M in Q3 2017.
- 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.
Based on Schwartz Investment Counsel's 13F filing for Q2 2018, filed 13 Aug 2018.